Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fezolinetant and Vascular Health and Brain Health

NCT07606664 is registered in ClinicalTrials.gov with Rebecca Thurston as lead sponsor.

NCT NCT07606664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fezolinetant and Vascular Health and Brain Health
Lead sponsor
Rebecca Thurston
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 25, 2026
Completion date
December 30, 2029
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

menopause hot flashes